Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Tobacco Use Disorder 2Rectal Neoplasms 2Precancerous Conditions 2Colorectal Neoplasms 2Colonic Neoplasms 2Barrett Esophagus 2Thromboembolism 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Multiple Pulmonary Nodules 1Lung Neoplasms 1Leukoplakia, Oral 1Leukemia, Hairy Cell 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Adenomatous Polyps 1Adenocarcinoma Of Esophagus 1

Interventions

Aspirin 2zileuton 1X-Rays 1Sulindac 1Spectroscopy, Fourier Transform Infrared 1Immunohistochemistry 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Tobacco Use Disorder × Aspirin × Clear all
NCT02169271 2020-05-21

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

National Cancer Institute (NCI)

Phase 2 Completed
109 enrolled 27 charts

Tobacco Use Disorder, Smoking Cessation, Multiple Pulmonary Nodules

NCT02123849 2018-08-29

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers

National Cancer Institute (NCI)

Phase 2 Completed
54 enrolled 15 charts
Thoracic

Lung Neoplasms, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡